Gait variability in Parkinson's disease: Levodopa and walking direction

M. S. Bryant, D. H. Rintala, J. G. Hou, R. L. Collins, E. J. Protas

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Levodopa treatment has been shown to improve gait spatio-temporal characteristics in both forward and backward walking. However, effect of levodopa on gait variability during backward walking compared with forward walking has not been reported. Aims of study: To study the effects of levodopa on gait variability of forward and backward walking in individuals with Parkinson's disease (PD). Methods: Forty individuals with PD were studied. Their mean age was 68.70 ± 7.46 year. The average time since diagnosis was 9.41 ± 5.72 year. Gait variability was studied while 'OFF' and 'ON' levodopa when the participants walked forward and backward at their usual speed. Variability in step time, swing time, stride length, double support time, and stride velocity were compared between medication condition and walking direction. Results: Variability of step time, swing time, stride length, and stride velocity decreased significantly during forward and backward walks (P <0.001; P <0.001; P = 0.003, P = 0.001, respectively) after levodopa administration. Variability of double support time was not changed after levodopa administration (P = 0.054). Conclusions: Levodopa had positive effects on gait variability of forward and backward walking in individuals with PD. However, variability in double support time was not affected by the levodopa.

Original languageEnglish (US)
JournalActa Neurologica Scandinavica
DOIs
StateAccepted/In press - 2015

Fingerprint

Levodopa
Gait
Walking
Parkinson Disease
Direction compound

Keywords

  • Backward walking
  • Forward walking
  • Gait variability
  • Levodopa
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Bryant, M. S., Rintala, D. H., Hou, J. G., Collins, R. L., & Protas, E. J. (Accepted/In press). Gait variability in Parkinson's disease: Levodopa and walking direction. Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.12505

Gait variability in Parkinson's disease : Levodopa and walking direction. / Bryant, M. S.; Rintala, D. H.; Hou, J. G.; Collins, R. L.; Protas, E. J.

In: Acta Neurologica Scandinavica, 2015.

Research output: Contribution to journalArticle

Bryant, M. S. ; Rintala, D. H. ; Hou, J. G. ; Collins, R. L. ; Protas, E. J. / Gait variability in Parkinson's disease : Levodopa and walking direction. In: Acta Neurologica Scandinavica. 2015.
@article{5209893fc27048dea4f58f3ebf1bf958,
title = "Gait variability in Parkinson's disease: Levodopa and walking direction",
abstract = "Background: Levodopa treatment has been shown to improve gait spatio-temporal characteristics in both forward and backward walking. However, effect of levodopa on gait variability during backward walking compared with forward walking has not been reported. Aims of study: To study the effects of levodopa on gait variability of forward and backward walking in individuals with Parkinson's disease (PD). Methods: Forty individuals with PD were studied. Their mean age was 68.70 ± 7.46 year. The average time since diagnosis was 9.41 ± 5.72 year. Gait variability was studied while 'OFF' and 'ON' levodopa when the participants walked forward and backward at their usual speed. Variability in step time, swing time, stride length, double support time, and stride velocity were compared between medication condition and walking direction. Results: Variability of step time, swing time, stride length, and stride velocity decreased significantly during forward and backward walks (P <0.001; P <0.001; P = 0.003, P = 0.001, respectively) after levodopa administration. Variability of double support time was not changed after levodopa administration (P = 0.054). Conclusions: Levodopa had positive effects on gait variability of forward and backward walking in individuals with PD. However, variability in double support time was not affected by the levodopa.",
keywords = "Backward walking, Forward walking, Gait variability, Levodopa, Parkinson's disease",
author = "Bryant, {M. S.} and Rintala, {D. H.} and Hou, {J. G.} and Collins, {R. L.} and Protas, {E. J.}",
year = "2015",
doi = "10.1111/ane.12505",
language = "English (US)",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Gait variability in Parkinson's disease

T2 - Levodopa and walking direction

AU - Bryant, M. S.

AU - Rintala, D. H.

AU - Hou, J. G.

AU - Collins, R. L.

AU - Protas, E. J.

PY - 2015

Y1 - 2015

N2 - Background: Levodopa treatment has been shown to improve gait spatio-temporal characteristics in both forward and backward walking. However, effect of levodopa on gait variability during backward walking compared with forward walking has not been reported. Aims of study: To study the effects of levodopa on gait variability of forward and backward walking in individuals with Parkinson's disease (PD). Methods: Forty individuals with PD were studied. Their mean age was 68.70 ± 7.46 year. The average time since diagnosis was 9.41 ± 5.72 year. Gait variability was studied while 'OFF' and 'ON' levodopa when the participants walked forward and backward at their usual speed. Variability in step time, swing time, stride length, double support time, and stride velocity were compared between medication condition and walking direction. Results: Variability of step time, swing time, stride length, and stride velocity decreased significantly during forward and backward walks (P <0.001; P <0.001; P = 0.003, P = 0.001, respectively) after levodopa administration. Variability of double support time was not changed after levodopa administration (P = 0.054). Conclusions: Levodopa had positive effects on gait variability of forward and backward walking in individuals with PD. However, variability in double support time was not affected by the levodopa.

AB - Background: Levodopa treatment has been shown to improve gait spatio-temporal characteristics in both forward and backward walking. However, effect of levodopa on gait variability during backward walking compared with forward walking has not been reported. Aims of study: To study the effects of levodopa on gait variability of forward and backward walking in individuals with Parkinson's disease (PD). Methods: Forty individuals with PD were studied. Their mean age was 68.70 ± 7.46 year. The average time since diagnosis was 9.41 ± 5.72 year. Gait variability was studied while 'OFF' and 'ON' levodopa when the participants walked forward and backward at their usual speed. Variability in step time, swing time, stride length, double support time, and stride velocity were compared between medication condition and walking direction. Results: Variability of step time, swing time, stride length, and stride velocity decreased significantly during forward and backward walks (P <0.001; P <0.001; P = 0.003, P = 0.001, respectively) after levodopa administration. Variability of double support time was not changed after levodopa administration (P = 0.054). Conclusions: Levodopa had positive effects on gait variability of forward and backward walking in individuals with PD. However, variability in double support time was not affected by the levodopa.

KW - Backward walking

KW - Forward walking

KW - Gait variability

KW - Levodopa

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84945271507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945271507&partnerID=8YFLogxK

U2 - 10.1111/ane.12505

DO - 10.1111/ane.12505

M3 - Article

C2 - 26399376

AN - SCOPUS:84945271507

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

ER -